101. Long-term results of treatment of benign central venous obstructions unrelated to dialysis with expandable Z stents.
- Author
-
Petersen BD and Uchida BT
- Subjects
- Adult, Aged, Budd-Chiari Syndrome complications, Catheterization, Central Venous adverse effects, Constriction, Pathologic therapy, Female, Follow-Up Studies, Humans, Liver Cirrhosis complications, Longitudinal Studies, Male, Middle Aged, Plasminogen Activators therapeutic use, Portal Vein injuries, Portal Vein surgery, Radiation Injuries complications, Renal Dialysis, Survival Rate, Thrombosis complications, Thrombosis drug therapy, Urokinase-Type Plasminogen Activator therapeutic use, Vascular Diseases etiology, Vascular Patency, Vena Cava, Inferior injuries, Vena Cava, Inferior surgery, Vena Cava, Superior injuries, Vena Cava, Superior surgery, Portal Vein pathology, Stents, Vascular Diseases therapy, Vena Cava, Inferior pathology, Vena Cava, Superior pathology
- Abstract
Purpose: To evaluate long-term patency of self-expanding Z stents for treatment of benign central venous obstructions unrelated to dialysis., Materials and Methods: Z stents were placed in 19 patients, (ages 26-72 years) with severe symptomatic obstructions of the superior or inferior venae cavae and their large branches and portal vein caused by surgical or catheter injury (n = 8), fibrosis (n = 5), cirrhosis (n = 3), Budd-Chiari syndrome (n = 2), and extrinsic compression (n = 1). Fourteen patients underwent stent placement primarily, five after local urokinase infusion for superimposed thrombosis. Follow-up was performed with ultrasound and venography., Results: Venous congestive symptoms quickly resolved in all patients after stent placement. The follow-up period was from 1 to 94 months. Twelve patients have died during follow-up from 1 to 37 months although all remained asymptomatic until death. Six patients remain alive, asymptomatic, with patent stents, and with follow-up from 24 to 94 months. Primary patency was 83%, and secondary patency was 100%. One patient with a patent stent at 12 months was lost to follow-up. No stent migrations, perforations, infections, or significant complications occurred., Conclusion: Benign central venous obstructions are effectively treated by the placement of self-expandable Z stents. Placed percutaneously into obstructive lesions with a minimum risk, these stents offer long-term durability and patency.
- Published
- 1999
- Full Text
- View/download PDF